Please use this identifier to cite or link to this item:
|Title:||Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004)||Authors:||Manfrin, Erminia
|Keywords:||Benign breast lesions;Breast cancer screening program;Fine-needle aspiration cytology;Lesions at risk of developing cancer;Needle biopsy||Keywords Plus:||ATYPICAL DUCTAL HYPERPLASIA;CORE NEEDLE BIOPSIES;CARCINOMA IN-SITU;TERM-FOLLOW-UP;SURGICAL EXCISION;DETECTED LESIONS;DISEASE;MALIGNANCY;DIAGNOSIS;UNDERESTIMATION||Mesh headings:||Biopsy;Breast Diseases;Breast Neoplasms||Secondary Mesh headings:||Aged;Biopsy, Needle;Early Detection of Cancer;Female;Humans;Mass Screening;Middle Aged;Risk||Issue Date:||1-Feb-2009||Publisher:||WILEY||Journal:||Cancer||Abstract:||
Cytology and core-needle biopsies are not always sufficient to exclude malignancy in benign breast lesions (BBL) that are at risk of developing cancer, and open biopsy often is mandatory. In screening programs, open biopsies performed for lesions that are at risk of developing malignancy are considered benign. The authors of this report evaluated the impact of the screen-detected BBL at risk of developing cancer that were counted in the quota of benign breast open biopsies in the Breast Cancer Screening Program of Verona.
|Appears in Collections:||Articles|
Show full item record
checked on May 3, 2021
checked on Sep 1, 2020
WEB OF SCIENCETM
checked on Nov 26, 2021
Page view(s) 201
checked on Nov 29, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.